학술논문

Increasing age and atrial arrhythmias are associated with increased thromboembolic events in a young cohort of adults with repaired tetralogy of Fallot
Document Type
Report
Source
Journal of Arrhythmia. December 2021, Vol. 37 Issue 6, p1546, 9 p.
Subject
Diseases
Complications and side effects
Risk factors
Atrial fibrillation -- Complications and side effects -- Risk factors
Tetralogy of Fallot -- Risk factors -- Complications and side effects
Thromboembolism -- Risk factors -- Complications and side effects
Medical research
Genetic disorders -- Complications and side effects -- Risk factors
Stroke -- Complications and side effects -- Risk factors
Ischemia -- Complications and side effects -- Risk factors
Adults
Medicine, Experimental
Stroke (Disease) -- Complications and side effects -- Risk factors
Language
English
ISSN
1880-4276
Abstract
INTRODUCTION Tetralogy of Fallot (TOF) is one of the most common complex heart defects, accounting for 7%‐10% of all congenital cardiac malformations.[sup.1] With surgical and medical advances in the last [...]
: Background: Adults with repaired Tetralogy of Fallot (rTOF) comprise one of the largest cohorts among adults with congenital heart disease (ACHD). These patients have a higher burden of atrial arrhythmias (AA), leading to increased adverse events, including stroke and transient ischemic attack (TIA). However, the data on factors associated with stroke/TIA in rTOF are limited, and classic risk factors may not apply. We studied event rates and associated factors for thromboembolism in a rTOF cohort. Methods: Retrospective cohort study of all adult patients age >18 years with rTOF followed at a single ACHD tertiary care center. AA of interest were atrial fibrillation (AF) and atrial flutter (AFL). Results: Data from 260 patients were identified, mean age 37.6 SD 13.3 years, followed over 5108 patient‐years (mean 16.6 SD 8.2 years). 43 patients had AF and/or AFL, and 30 patients had thromboembolic events, of which 19 patients had stroke/TIA. The event rate for any thromboembolism was 3.39 per 100 patient‐years follow‐up in patients with AA, compared to 1.80 in patients without (P =.07). In univariate analysis, older age and diabetes were associated with thromboembolic events. In multivariate analysis, only older age was associated with thromboembolic events. Conclusions: In our relatively young cohort of adults with rTOF, there was a high prevalence of AA, associated with nearly double the rate of thromboembolic events compared to patients without AA. Older age alone is independently associated with thromboembolic events. Further studies into assessment of silent AA are required, and routine assessments should be considered at an earlier age.